Correction to: Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study

Huang, Tang-Hsiu; Kuo, Chin-Wei; Chen, Chian-Wei; Tseng, Yau-Lin; Wu, Chao-Liang; Lin, Sheng-Hsiang

doi:10.1186/s12890-021-01559-7

Correction to: Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study

Correction
Open access
Published: 08 June 2021

Volume 21, article number 193, (2021)
Cite this article

Download PDF

You have full access to this open access article

BMC Pulmonary Medicine Aims and scope Submit manuscript

Correction to: Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study

Download PDF

Tang-Hsiu Huang^1,2,
Chin-Wei Kuo^1,2,
Chian-Wei Chen¹,
Yau-Lin Tseng³,
Chao-Liang Wu⁴ &
…
Sheng-Hsiang Lin^2,5,6

955 Accesses
Explore all metrics

The Original Article was published on 15 May 2021

Correction to: BMC Pulm Med (2021) 21:165 https://doi.org/10.1186/s12890-021-01530-6

Following publication of the original article [1], it was brought to our attention that panel ‘e’ was missing from Fig. 2; the figure has since been corrected in the published article.

Reference

Huang TH, Kuo CW, Chen CW, et al. Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study. BMC Pulm Med. 2021;21:165. https://doi.org/10.1186/s12890-021-01530-6.
Article PubMed PubMed Central Google Scholar

Download references

Author information

Authors and Affiliations

Division of Chest Medicine, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
Tang-Hsiu Huang, Chin-Wei Kuo & Chian-Wei Chen
Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan
Tang-Hsiu Huang, Chin-Wei Kuo & Sheng-Hsiang Lin
Division of Thoracic Surgery, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
Yau-Lin Tseng
Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, Tainan, Taiwan
Chao-Liang Wu
Department of Public Health, College of Medicine, National Cheng-Kung University, Tainan, Taiwan
Sheng-Hsiang Lin
Biostatistics Consulting Center, National Cheng Kung University Hospital, College of Medicine, National Cheng-Kung University, Tainan, Taiwan
Sheng-Hsiang Lin

Authors

Tang-Hsiu Huang
View author publications
You can also search for this author in PubMed Google Scholar
Chin-Wei Kuo
View author publications
You can also search for this author in PubMed Google Scholar
Chian-Wei Chen
View author publications
You can also search for this author in PubMed Google Scholar
Yau-Lin Tseng
View author publications
You can also search for this author in PubMed Google Scholar
Chao-Liang Wu
View author publications
You can also search for this author in PubMed Google Scholar
Sheng-Hsiang Lin
View author publications
You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sheng-Hsiang Lin.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Cite this article

Huang, TH., Kuo, CW., Chen, CW. et al. Correction to: Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study. BMC Pulm Med 21, 193 (2021). https://doi.org/10.1186/s12890-021-01559-7

Download citation

Published: 08 June 2021
DOI: https://doi.org/10.1186/s12890-021-01559-7

Correction to: Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study

Correction to: BMC Pulm Med (2021) 21:165 https://doi.org/10.1186/s12890-021-01530-6

Reference

Author information

Authors and Affiliations

Corresponding author

Additional information

Publisher's Note

Rights and permissions

About this article

Cite this article

Share this article

Search

Navigation